Company Spotlight features video, webcasts, presentations and annual reports for more than 30,000 companies. Sign up to promote your company. ×
Horizon Pharma, Inc.
Pharmaceutical Preparations IL, United States
Nasdaq: HZNP
Company Description
Horizon Pharma, Inc. is a biopharmaceutical company that is developing and commercializing innovative medicines to target unmet therapeutic needs in arthritis, pain and inflammatory diseases. It has received FDA approval for DUEXIS, a novel tablet formulation containing a fixed-dose combination of ibuprofen and famotidine in a single pill. The company's product portfolio comprises of DUEXIS, NP01/LODOTRA, TruNoc and HZN-602. It intends to commercialize its products in the United States to explore co-promotion opportunities for DUEXIS in the United States, and to enter into licensing or additional distribution agreements for commercialization of its products outside the United States. The company was founded on March 23, 2010 and is headquartered in Deerfield, IL.
Similar to: Apricus Biosciences, Inc., Mast Therapeutics, Inc., United-Guardian, Inc.
Featured Company
Alexco Resource Corp.
Vancouver, BC, CA
Canadas Only Primary Silver Producer Alexco owns and operates the Bellekeno silver mine, Canadas only operating primary silver… Learn more →
Social Monitor
You may also be interested in:
United-Guardian, Inc.
Hauppauge, NY, US
United-Guardian, Inc. engages in the research, development, manufacture, and marketing of cosmetic ingredients, personal and health… Learn more →
Mast Therapeutics, Inc.
San Diego, CA, US
ADVENTRX Pharmaceuticals is a specialty pharmaceutical company focused on developing proprietary product candidates. The Companys… Learn more →
Apricus Biosciences, Inc.
San Diego, CA, US
Apricus Bio, a San Diego based revenue-generating pharmaceutical company, has leveraged the flexibility of its clinically-validated… Learn more →